SARS-CoV-2 triggering autoimmune diseases
- PMID: 35461172
- PMCID: PMC8979824
- DOI: 10.1016/j.cyto.2022.155873
SARS-CoV-2 triggering autoimmune diseases
Abstract
Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of reasons. Viruses are thought to be important environmental elements that contribute to the development of autoimmune antibodies. It seems that viruses cause autoimmunity with mechanisms such as molecular mimicry, bystander activation of T cells, transient immunosuppression, and inflammation, which has also been seen in post-Covid-19 autoimmunity. Infection of respiratory epithelium by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dysregulates the immune response, triggers both innate and acquired immunity that led to the immune system's hyperactivation, excessive cytokine secretion known as "cytokine storm," and finally acute respiratory distress syndrome (ARDS) associated with high mortality. Any factor in the body that triggers chronic inflammation can contribute to autoimmune disease, which has been documented during the Covid-19 pandemic. It has been observed that some patients produce autoantibody and autoreactive CD4+ and CD8+ T cells, leading to the loss of self-tolerance. However, there is a scarcity of evidence defining the precise molecular interaction between the virus and the immune system to elicit autoreactivity. Here, we present a review of the relevant immunological findings in Covid-19 and the current reports of autoimmune disease associated with the disease.
Keywords: Autoimmune disease; Autoimmunity; Covid-19; Cytokine; SARS-CoV-2.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Similar articles
-
The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals.Med Hypotheses. 2020 Dec;145:110345. doi: 10.1016/j.mehy.2020.110345. Epub 2020 Oct 14. Med Hypotheses. 2020. PMID: 33080459 Free PMC article.
-
COVID-19: A trigger of autoimmune diseases.Cell Biol Int. 2023 May;47(5):848-858. doi: 10.1002/cbin.11997. Epub 2023 Feb 5. Cell Biol Int. 2023. PMID: 36740221 Review.
-
Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.Int Immunopharmacol. 2022 Nov;112:109183. doi: 10.1016/j.intimp.2022.109183. Epub 2022 Aug 22. Int Immunopharmacol. 2022. PMID: 36182877 Free PMC article. Review.
-
The SARS-CoV-2 as an instrumental trigger of autoimmunity.Autoimmun Rev. 2021 Apr;20(4):102792. doi: 10.1016/j.autrev.2021.102792. Epub 2021 Feb 19. Autoimmun Rev. 2021. PMID: 33610751 Free PMC article. Review.
-
SARS-CoV-2 infection as a trigger of autoimmune response.Clin Transl Sci. 2021 May;14(3):898-907. doi: 10.1111/cts.12953. Epub 2021 Jan 21. Clin Transl Sci. 2021. PMID: 33306235 Free PMC article.
Cited by
-
Blood-derived product therapies for SARS-CoV-2 infection and long COVID.MedComm (2020). 2023 Nov 15;4(6):e426. doi: 10.1002/mco2.426. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38020714 Free PMC article. Review.
-
The mosaic of autoimmunity - Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens.Autoimmun Rev. 2022 Oct;21(10):103166. doi: 10.1016/j.autrev.2022.103166. Epub 2022 Aug 4. Autoimmun Rev. 2022. PMID: 35932955 Free PMC article.
-
SARS-CoV-2 Gut-Targeted Epitopes: Sequence Similarity and Cross-Reactivity Join Together for Molecular Mimicry.Biomedicines. 2023 Jul 7;11(7):1937. doi: 10.3390/biomedicines11071937. Biomedicines. 2023. PMID: 37509576 Free PMC article.
-
"Multisystem Inflammatory Syndrome in Children"-Like Disease after COVID-19 Vaccination (MIS-V) with Potential Significance of Functional Active Autoantibodies Targeting G-Protein-Coupled Receptors (GPCR-fAAb) for Pathophysiology and Therapy.Children (Basel). 2023 Nov 22;10(12):1836. doi: 10.3390/children10121836. Children (Basel). 2023. PMID: 38136038 Free PMC article.
-
Seronegative Myasthenia Gravis with Concomitant SARS-CoV-2 Infection in a Dog.Vet Sci. 2022 Jun 24;9(7):318. doi: 10.3390/vetsci9070318. Vet Sci. 2022. PMID: 35878335 Free PMC article.
References
-
- Sarda S.R., Tekale S.U., Kótai L., Domb A.J., Pawar R.P. COVID-19: A global pandemic. Eur. Chem. Bull. 2020;9(8):266–272.
-
- Raheem R., Alsayed R., Yousif E., Hairunisa N. Coronavirus new variants: the mutations cause and the effect on the treatment and vaccination: Coronavirus new Variants: effect and treatments. Baghdad J. Biochem. Appl. Biol. Sci. 2021;2(02):70–78.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous